Osteoclasts at Bone Remodeling: Order from Order

Area of Science:

• Cell Biology
• Bone Biology
• Developmental Biology

Background:

• Osteoclasts, multinucleated bone-resorbing cells, originate from the monocyte/macrophage lineage.
• The macrophage colony-stimulating factor/receptor activator of nuclear factor κB ligand (M-CSF/RANKL) signaling pathway regulates osteoclast differentiation.
• Traditional understanding posits osteoclast apoptosis post-resorption, but in vivo studies reveal nucleus replacement mechanisms.

Approach:

• Reviewing current literature on osteoclastogenesis, focusing on mechanisms driving heterogeneity and plasticity.
• Examining candidate processes such as asymmetric cell division, niche interactions, self-organization, and fusion/fission dynamics.
• Analyzing the role of the M-CSF/RANKL network in governing osteoclast formation and behavior.

Key Points:

• In vivo osteoclastogenesis involves nucleus replacement in existing cells, minimizing de novo osteoclast formation.
• Osteoclast size is dynamic, influenced by cell fusion and fission in response to environmental cues.
• In vitro osteoclastogenesis exhibits heterogeneity in precursors, fusion modes, and differentiated cell properties.

Conclusions:

• Mechanisms like asymmetric cell division, niche factors, self-organization, and fusion/fission contribute to osteoclast heterogeneity.
• Further research into the plasticity and fluctuations of the M-CSF/RANKL network is crucial for understanding bone remodeling.
• Elucidating these complex processes offers insights into bone diseases and potential therapeutic targets.